Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository (“Registry”)
Zeynep Belce Erton(Hospital for Special Surgery), Doruk Erkan(Hospital for Special Surgery), Vittorio Pengo(University of Padua), Maria Efthymiou(University College London), Nina Kello(Northwell Health), Savino Sciascia(Ospedale San Giovanni Bosco), Ann E. Clarke(University of Calgary), Alí Duarte‐García(Mayo Clinic in Arizona), María Laura Bertolaccini(St Thomas' Hospital), Pier Luigi Meroni(IRCCS Istituto Auxologico Italiano), Hui Shi(Hebei Medical University), Rebecca Karp Leaf(California University of Pennsylvania), D. Paredes(BioCruces Health research Institute), Leslie Skeith(University of Calgary), Bahar Artım-Esen(Istanbul University), Ricard Cervera(Hospital Clínic de Barcelona), José Pardos‐Gea(Vall d'Hebron Hospital Universitari), Yu Zuo(University of Michigan), Massimo Radin(Ospedale San Giovanni Bosco), Giulia Pazzola(Azienda Sanitaria Unità Locale di Reggio Emilia), H. Michael Belmont(New York University), Rosana Quintana(Hospital Provincial de Rosario), Rohan Willis(The University of Texas Medical Branch at Galveston), Laura Andréoli(Institute for Rheumatic Diseases (Japan)), C. López-Pedrera(Instituto Maimónides de Investigación Biomédica de Córdoba), D. Ware Branch(University of Utah), Hannah Cohen(University College London Hospitals NHS Foundation Trust), Maria G. Tektonidou(National and Kapodistrian University of Athens), Paul R. Fortin(Centre hospitalier de l'Université Laval), Zhouli Zhang(Peking University), Tatsuya Atsumi(Hokkaido University), Michelle Petri(Johns Hopkins University), Danieli Andrade(Universidade de São Paulo), Megan R W Barber(University of Calgary), Esther Rodríguez-Almaraz(Hospital Universitario 12 De Octubre), Robert Roubey(Center for Rheumatology), Guilherme Ramires de Jesús(Universidade do Estado do Rio de Janeiro)
Cited by 2
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k
Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis
|New England Journal of Medicine|2005|1.1k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
The immune cell landscape in kidneys of patients with lupus nephritis
|Nature Immunology|2019|840